These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12640959)

  • 41. New advances and novel treatments in heart failure.
    Smith AL; Brown CS
    Crit Care Nurse; 2003 Feb; Suppl():11-8; quiz 19-20. PubMed ID: 12640965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is nesiritide really that good or that bad?
    Cheng TO
    Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525
    [No Abstract]   [Full Text] [Related]  

  • 43. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
    Silver MA
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department.
    Chandra A; Otero R; Freeman D; Cairns CB
    Ren Fail; 2008; 30(1):45-50. PubMed ID: 18197542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nesiritide in acute heart failure.
    de Moraes Barros GD; de Carvalho Leite CR
    Lancet; 2003 Sep; 362(9388):999. PubMed ID: 14511941
    [No Abstract]   [Full Text] [Related]  

  • 46. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 47. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T; Perrier A
    Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.
    Feldman DS; Sun B
    Heart Fail Rev; 2004 Jul; 9(3):203-8. PubMed ID: 15809818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract]   [Full Text] [Related]  

  • 51. Recommendations for the clinical use of cardiac natriuretic peptides.
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ;
    Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
    Hiestand B; Abraham WT
    Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S; Clarke K; Srinivasan V; Gradman A
    QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and tolerability of serial home infusions of nesiritide for advanced heart failure.
    Chung ES; Menon SG; Daly KA; Atkinson J; Peterson T; Robertson R; Ibanez K; Kereiakes DJ
    Am J Cardiol; 2006 May; 97(9):1370-3. PubMed ID: 16635613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA; Wahlstrom HD
    Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
    Jain P; Massie BM; Gattis WA; Klein L; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S3-17. PubMed ID: 12594447
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
    Elkayam U; Akhter MW; Singh H; Khan S; Usman A
    Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous nesiritide in acute heart failure.
    Knox MA; Dancy T; Mook W; Pschirer JJ
    Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.